Table 3. Stalk preservation and postoperative endocrine outcomes.
| Epoch | Total N = 58 a | 2005–2010 ( N = 16) | 2011–2015 ( N = 23) |
2016–2020 ( N = 21) | ||
|---|---|---|---|---|---|---|
| Anterior pituitary function | Normal endocrine function | 9 (15.5%) | 4 (25.0%) | 0 (0) | 5 (23.8%) | 0.001 |
| Normal to partial | 15 (25.8%) | 0 (0) | 7 (30.4%) | 8 (38.1%) | ||
| Normal to pan-hypopituitarism | 19 (32.7%) | 3 (18.8%) | 8 (34.8%) | 8 (38.1) | ||
| Partial to pan-hypopituitarism | 2 (3.4%) | 1 (6.3%) | 1 (4.3%) | 0 | ||
| Stable pan-hypopituitarism | 9 (15.5%) | 3 (18.8%) | 6 (26.1%) | 0 | ||
| Stable partial hypopituitarism | 7 (12.1%) | 6 (37.5%) | 1 (4.3%) | 0 | ||
| DI | Preoperative DI | 6 (10.3%) | 2 (12.5%) | 4 (17.3) | 0 (0%) | 0.12 |
| New permanent | 34 (58.6%) | 6 (37.5%) | 13 (68.4%) | 15 (71.4%) | 0.078 | |
| Infundibulum status b | Preserved | 24 (49%) | 13 (100%) | 1 (5.9%) | 10 (52.6%) | 0.0001 |
| Sacrificed | 25 (51%) | 0 (0) | 16 (94.1%) | 9 (47.4%) |
a
Eight patients without follow-up for endocrine functions.
b
Seventeen patients were excluded from infundibulum status analysis due to stalk not identified/prior sacrifice/indeterminate. Forty-nine patients were included.
Bold values indicate significant level less than 0.05.